Nutrigenomics Market Size, Share & Trends Analysis Report By Applications (Digestive Health, Immune Health, Women's Health, Others), By Service (Nutrigenomic Genetic Testing for Clinical Purposes, Nutrigenomic Genetic Testing for Research Purposes), By Products (Probiotics, Prebiotics) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Nutrigenomics Market Size & Growth Analysis

The global nutrigenomics market size was valued at USD 1.99 billion in 2025 and is projected to grow from USD 2.33 billion in 2026 to USD 8.34 billion by 2034, registering a CAGR of 17.26% during the forecast period from 2026 to 2034. North America dominated the nutrigenomics market with a market share of 39.4% in 2025.

Key Market Indicators

• North America dominated the nutrigenomics market in 2024, holding around 39% share valued at USD 663 million, supported by advanced healthcare infrastructure, high consumer awareness of personalized nutrition, and the strong presence of genetic testing companies.
• Based on application, the digestive health segment dominated the global nutrigenomics market in 2024 and is projected to grow at a CAGR of 15.44%, driven by the rising prevalence of gut-related illnesses and the growing adoption of microbiome-based therapeutic interventions.
• Based on service, the nutrigenomics testing for clinical purposes segment accounted for the highest share in 2024 and is anticipated to expand at a CAGR of 14.09%, supported by the increasing use of predictive genetic testing to provide personalized nutrition and lifestyle solutions.
• Based on products, the probiotics segment held the largest share of the global market in 2024 and is expected to grow at a CAGR of 16.43%, fueled by their proven benefits on gut health and strong consumer adoption worldwide.

Market Size & Forecast

• 2024 Market Size: USD 1.7 Billion
• 2033 Projected Market Size: USD 7.15 Billion
• CAGR (2025–2033): 17.26%
• Asia-Pacific: Largest market in 2024
• North America: Fastest-growing region

Market Segmentation

Application Insights

The digestive health segment dominates the global market and is anticipated to grow at a CAGR of 15.44% over the forecast period. The human gastrointestinal tract is home to a highly complex and diverse microbial community, with microbial cells outnumbering human cells with a ratio of 10:1. Disruption of the gut microbiota is increasingly being realized to be highly significant for metabolic diseases such as malnutrition, diabetes, chronic inflammatory bowel diseases (both ulcerative colitis and Crohn's Disease), and pathological diseases such as C. difficile infections and Enterotoxic E. coli infections. The connection between disruptions in the gut microbiome and metabolic diseases has been well-documented through tools like high-throughput sequencing, 16s rRNA sequencing, and non-genomic techniques, leading to a very high number of therapeutic interventions for gut-related illnesses.

The immune system within the human body is composed of a highly complex network of innate and adaptive components endowed with an extraordinary ability to adapt and respond to diversified challenges. Collectively acting as a formidable regulator of cellular homeostasis within the host, this intricate system allows the sustenance and restoration of tissue function for encounters of environmental and microbial natures. The coincidence of the defined arms of the immune system with the acquired microbiota has been well-documented to exert a symbiotic relationship for the optimal functioning of human machinery.

Request Customizationto receive a tailored report.

Service Insights

The nutrigenomics testing market for the clinical purpose segment is responsible for the highest market share and is anticipated to exhibit a CAGR of 14.09% over the forecast period. Genes code every aspect of our health and are the building blocks of our life. Hence, gaining optimum health and well-being requires an efficient knowledge of our genes. Various aspects of health are directly or indirectly governed by the nutrition we take and impact our genes. The predictive testing of such genes with the help of technology can assist in analyzing our health and can reduce the risk of disease conditions through lifestyle management. Further, the predictive testing of the genes also eliminates the idea of a "one size fits all" approach to the healthcare system. It would offer a personalized solution as per the individual's genetic composition.

Products Insights

The probiotics segment owns the highest market share and is expected to grow at a CAGR of 16.43% during the forecast period. Probiotics are live microbes that are consumed for health benefits. Probiotics have well-documented effects on the gut microbiome, led by the effects conferred by the first-ever commercialized probiotic, Yakult. A dairy-based probiotic drink, Yakult, was launched in 1935 and has been extensively used worldwide, turning over monumental amounts of sales.

Prebiotics are generally described as substrates that aid in the growth of beneficial microbes inside the human body, primarily the gut, which helps maintain the microbial equilibrium in the body. The improved knowledge regarding the composition of the human microbiota and advancing studies into designing the optimal nutritional supplement for the beneficial microbes within the human body have provided a broader scope for categorizing prebiotics. With the increasing number of microbes having modulatory capabilities within the human microbiota and the expanding knowledge regarding the different effects conferred by the interaction of different compounds with the human microbiota, prebiotics have become more inclusive as nutritional supplements.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global market shareholder and is anticipated to exhibit a CAGR of 20.10% during the forecast period. The North American nutrigenomics industry is expected to be driven by the growing prominence of health-conscious dietary habits and technological advancements. A high prevalence of different medical conditions, such as obesity, lactose intolerance, and inflammatory bowel disease in the region, fuels the market growth. Additionally, substantial investments in nutrigenomic testing and diet due to increasing health awareness further drive regional market growth. Similarly, establishing reimbursement scenarios by developing evidence-based, authorized data proving several benefits of nutrigenomic supplements provides tremendous opportunities for market growth in the region. Moreover, the collaboration of key market players with physicians to promote the adoption of a nutrigenomic diet and testing will enhance the future market growth. The U.S. was the leading contributor to the North American market owing to the launch of genetic testing and food items focusing on nutrigenetics.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Nutrigenomics Market Trend

Europe is estimated to exhibit a CAGR of 16.98% over the forecast period. The European market is a lucrative market with immense growth potential. Growing consciousness of the health disorders resulting from a change in lifestyles, increasing prominence of preventive medicine and health-conscious dietary habits, raising awareness about the diet-disease relationship, and a growing geriatric population are the significant factors driving the regional market growth. The nutrigenetics-based diet and genetic tests are most widely used in the developing nations of Central and Eastern Europe. In addition, several European countries, including France, Germany, the U.K., France, Spain, and Italy, are working persistently to enhance the adoption of nutrigenomics genetic testing for children across Europe. In contrast to the leading countries contributing significantly to the European market, the market for nutrigenomics in Germany is anticipated to see the highest growth in the forecast period. Furthermore, investments in genetic testing by the leading firms to promote the adoption of genetic testing and usage of probiotic-based supplements are fuelling the development of the market in Germany.

The expanding economies in the Asia-Pacific region are witnessing an improving awareness of the nutrigenetics-based diet and genetic tests. The expanding population of the region and increasing genetic association of several diseases impacted by dietary patterns have fueled the expansion of the market. In addition, the rising prevalence of different types of digestive illnesses, such as inflammatory bowel disease (IBD), lactose intolerance, and gastrointestinal disorders, is stimulating the market growth in the region. The growing awareness about the diet-disease relationship is increasing the demand for genetic tests in the region. Also, increasing demand for health-conscious dietary products is boosting the market growth in the region.

Latin American Nutrigenomics Market Trend

The Latin American market is anticipated to grow considerably in the forecast period. The region holds a significant opportunity for expansion by the key players of the global market. The growing geriatric population of the region and the high prevalence of several digestive diseases are the pivotal factors propelling the growth of the Latin American market. Moreover, the emergence of nutrigenomic testing has also paved the way for market expansion in the region. However, ambiguous food supplement regulations hamper nutrigenomics growth in Latin America.

The Rest-of-the-World region constitutes the Middle East, Africa, the Caribbean, and Oceania regions. The predicted growth is attributed to the rise in the prevalence of different digestive disorders and the growing prominence of preventive medicine. Further, the increasing awareness of the benefits associated with probiotics propels the growth of the Rest-of-the-World nutrigenomics industry.

List of Key and Emerging Players in Nutrigenomics Market